Skip to main content
TDOC logo

TDOC

Teladoc Health, Inc.
$9.65 +0.37 (+3.99%) At close · Jul 13
Market Cap
$1.74B
Shares
180,513,087

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$2.53B -1.5%
FY2025 Revenue FY2015–FY2025
Net Income
-$200.32M +80%
FY2025 Net Income FY2015–FY2025
Gross Margin
69.2% -4.4pp
FY2018 Gross Margin FY2015–FY2018
Operating Margin
-10.39% +29.3pp
FY2025 Operating Margin FY2015–FY2025
Diluted EPS
-$1.14 +80.6%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
$294.36M +0.2%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
$2.48B – $2.58B $2.51B $2.53B $2.57B $2.6B $2.41B $2.03B $1.09B $553.31M $417.91M $233.28M $123.16M $77.38M
-$142K -$9.27M -$80.37M -$60.5M -$29.01M -$26.11M -$17.49M -$2.59M -$2.2M
$755.14M $743.99M $650.26M $390.83M $184.47M $128.74M $61.62M $31.97M $21.04M
$310.28M $289.17M $171.66M $91.19M $56.34M
69.2% 73.58% 74.04% 72.81%
$275.83M $277.92M $307.27M $348.52M $333.63M $311.88M $164.94M $64.64M $54.37M $34.46M $21.82M $14.21M
$421.21M $431.89M $435.49M $464.66M $449.86M $438.01M $497.81M $157.69M $116.92M $79.78M $48.57M $54.84M
$356.29M $350.76M $363.37M $325.93M $244.6M $195.3M $64.7M $35.6M $31.5M $15.3M $6.1M $3.7M
$315.27M $256.03M $204.24M $69.5M $38.95M $35.6M $19.1M $8.27M $4.86M
$18.79M $20.36M $1.21M
$2.72B $2.79B $3.59B $2.85B $16.06B $2.3B $1.6B $633.75M
-$204.11M -$262.96M -$1.02B -$248.55M -$13.65B -$265.63M -$506.42M -$80.44M -$70.85M -$75.39M -$62.66M -$55.79M
-10.39% -39.73% -9.55% -567.27% -13.07% -46.29% -14.54% -16.95% -32.32% -50.88% -72.09%
-$3.71B -$13.4B -$61.39M -$436.93M -$41.49M -$35.25M -$56.3M -$54.39M -$50.92M
$19.32M $19.71M $23.8M $22.28M
$30.59M $36.77M $57.07M $46.78M
$7.74M $10.37M -$6.04M $4.45M -$859K $5.09M
-$185.11M -$235.53M -$993.65M -$219.61M -$13.66B -$384.66M -$575.99M -$109.46M -$96.97M -$107.01M -$73.71M -$57.98M
-$13.96M -$35.21M $7.59M $760K -$3.81M $44.14M -$90.86M -$10.59M $118K -$225K $510K $36K
-$171.15M -$200.32M -$1B -$220.37M -$13.66B -$428.79M -$485.14M -$98.86M -$97.08M -$106.78M -$74.22M -$58.02M
-7.92% -38.97% -8.47% -567.53% -21.09% -44.35% -17.87% -23.23% -45.77% -60.26% -74.98%
-$74.22M -$58.02M
-$169.32M -$196.66M -$1B -$214.58M -$13.7B -$453.6M -$449.38M -$103.03M -$114.24M -$102.69M -$74.18M -$58.06M
USD/shares -$1.14 -$5.87 -$1.34 -$84.60 -$2.73
USD/shares -$1.14 -$5.87 -$1.34 -$84.60 -$2.73
shares 176.22M 170.56M 164.58M 161.46M 156.94M 90.51M 71.84M 65.84M 55.43M 42.33M 19.92M
shares 176.22M 170.56M 164.58M 161.46M 156.94M 90.51M 71.84M 65.84M 55.43M 42.33M 19.92M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2016: $736K in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Health Information Services median 1.34×
EV/EBIT
Health Information Services median 25.34×
P/E (TTM)
Health Information Services median 34.37×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Teladoc Health Integrated Care $1,579,610,000 $1,528,870,000 $1,468,794,000 $1,373,900,000 $1,300,878,000 $744,309,000
BetterHelp $950,367,000 $1,040,704,000 $1,133,621,000 $1,019,646,000 $721,238,000 $345,105,000

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
United States $2,071,739,000 $2,159,959,000 $2,237,533,000 $2,101,015,000 $1,774,024,000 $913,720,000 $423,300,000 $342,700,000
Non Us $458,238,000 $409,615,000 $364,882,000 $305,825,000 $258,683,000 $180,242,000 $130,000,000 $75,200,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Access Fees Revenue $2,091,941,000 $2,215,220,000 $2,282,521,000 $2,103,814,000
Other $438,036,000 $354,354,000 $319,894,000 $303,026,000
Other Revenue $292,537,000 $246,707,000 $0
Subscription Access Fees $1,740,170,000 $847,255,000 $454,206,000 $350,784,000
Visit Fee Revenue $99,101,000 $67,123,000
Key facts CIK 1477449 CUSIP 87918A105 13F (30d) 41 filings 16 filers Visit website Investor relations